ArticleFrontiers in endocrinology2025
Association of the atherogenic index of plasma and other lipid indices with abnormal glucose metabolism in patients with ischemic stroke.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of key metabolic indicators associated with the comorbidity of ischemic stroke and diabetes mellitus using an optimal interpretable clinlabomics model.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the relationship of the atherogenic index of plasma (AIP) and other lipid indices with prediabetes mellitus (Pre-DM) and type 2 diabetes mellitus (T2DM) in patients with ischemic stroke (IS), with a focus on exploring the clinical application value of AIP in the assessment of glucose metabolism disorders. Methods: This study was conducted for the first time based on a large-scale IS cohort. 18,604 patients with IS were enrolled and subjected to comprehensive lipid profile assessments. The correlation between AIP and other commonly used lipid indices was systematically compared. Based on glucose levels, the patients were divided into three groups: normal glucose (NG), Pre-DM, and T2DM. The relationship of AIP and other lipid indices with Pre-DM and T2DM was evaluated through multivariable logistic regression. Furthermore, the dose-response correlation of AIP with Pre-DM and T2DM across varying genders and age groups was explored through the Restricted Cubic Spline (RCS) model, which was employed to analyze non-linear associations between variables. Results: We found that triglyceride (TG), total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C)/HDL-C, TG/HDL-C, non-HDL-C, remnant cholesterol (RC), RC/HDL-C, and AIP were all positively correlated with Pre-DM and T2DM. Notably, AIP demonstrated the highest specificity in this context. AIP was then divided into tertiles, with the T3 group showing the strongest correlation with both conditions compared with the T1 group. The correlation was stronger among females and patients aged ≥60 years. RCS analysis further indicated a non-linear positive dose-response relationship between AIP and T2DM across all genders and ages. Conclusion: In IS patients, AIP exhibits a stronger association with Pre-DM and T2DM than other lipid indices, especially in female patients and those aged 60 years and above.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.